Assess Consistency of Immunogenicity of GlaxoSmithKline Biologicals' Pandemic Influenza Vaccine (GSK1562902A) in Adults

Clinical trial NCT00449670 · COMPLETED

Trial details

NCT number: NCT00449670
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Influenza Influenza Vaccines

Start date: 2007-03-24
Primary completion: 2007-07-12
Enrollment: 1206

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.